Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies
Pre-operative chemoradiotherapy reduces local recurrence rates in locally advanced rectal cancer. 10-20% of patients undergo complete response to chemoradiotherapy, however, many patients show no response. The mechanisms underlying this are poorly understood; identifying molecular and immunological...
Main Authors: | Michael A. Gillespie, Colin W. Steele, Tamsin R.M. Lannagan, Owen J. Sansom, Campbell S.D. Roxburgh |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-06-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | https://oncologyreviews.org/site/article/view/511 |
Similar Items
-
Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma
by: Ali Shamseddine, et al.
Published: (2020-10-01) -
Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients
by: Hans Van Hulle, et al.
Published: (2020-10-01) -
Current status of intensified neo-adjuvant systemic therapy in locally advanced rectal cancer
by: Benedikt eEngels, et al.
Published: (2012-05-01) -
Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients
by: Xiang Hu, et al.
Published: (2019-05-01) -
Radiosensitivity of Cancer Stem Cells Has Potential Predictive Value for Individual Responses to Radiotherapy in Locally Advanced Rectal Cancer
by: Caterina Puglisi, et al.
Published: (2020-12-01)